Sequential and Site-Specific Delivery of Dual Anticancer Therapeutics Using Programmed Nanodepots

摘要

Gelipo based design for sequential and site-specific delivery of TRAIL and Dox will open an avenue for the exploration of more sophisticated drug derlivery systems, which can synergistically differentiate the extracellular and intracellular target to promote a superior anticancer effect.